2016 Election Abortion Bioethics Doctor-Patient Relationship FDA Health Law Policy Pharmaceuticals Reproductive Technology Wendy Salkin
FDA
-
-
Biosimilars – In The Pipeline or Still a Pipe Dream?
Read more: Biosimilars – In The Pipeline or Still a Pipe Dream? -
Are The FDA’s New Definitions And Labeling Requirements Good For Us, Or Just Empty Calories?
Read more: Are The FDA’s New Definitions And Labeling Requirements Good For Us, Or Just Empty Calories? -
What do doctors know about FDA drug approval standards and the breakthrough therapy designation? Less than we’d hope.
Read more: What do doctors know about FDA drug approval standards and the breakthrough therapy designation? Less than we’d hope. -
Regulating genetically modified mosquitoes
Read more: Regulating genetically modified mosquitoes -
Jacobus and Catalyst Continue to Race for Approval of LEMS Drug
Read more: Jacobus and Catalyst Continue to Race for Approval of LEMS Drug -
Peeling the Onion: How to Promote Pharmaceutical Innovation and Access to Medicine
Read more: Peeling the Onion: How to Promote Pharmaceutical Innovation and Access to Medicine -
UDI Adoption: A Necessary Step Towards Better Care for Patients with Implanted Devices
Read more: UDI Adoption: A Necessary Step Towards Better Care for Patients with Implanted Devices -
Bureaucracy Can Save Lives – The Legacy of Dr. Frances Kelsey
Read more: Bureaucracy Can Save Lives – The Legacy of Dr. Frances Kelsey -
The FDA’s Determination On Artificial Trans Fat: A Long Time Coming
Read more: The FDA’s Determination On Artificial Trans Fat: A Long Time Coming